Odia Y, Koschmann C, Vitanza NA, de Blank P, et al. Safety and pharmacokinetics of ONC201 (dordaviprone) administered two consecutive days per week in pediatric patients with H3K27M-mutant glioma. Neuro Oncol 2024 Feb 24:noae001. doi: 10.1093.
PMID: 38400780